Dailypharm Live Search Close

Fresenius Kabi launches 2 Ntense amino acid solutions

By Eo, Yun-Ho | translator Kang, Shin-Kook

24.08.02 05:23:43

°¡³ª´Ù¶ó 0
Ntense, an appropriate parenteral nutrition option for critically ill patients

Ntense EF is the only Intradialytic Parenteral Nutrition (IDPN) option available among three-chamber bag systems


On the 1st, Fresenius Kabi Korea (CEO&President: Noah Park) announced the launch of its high-strength amino acid nutritional solutions ¡®Ntense¡¯ and ¡®Ntense EF¡¯ in Korea.

Ntense, which stands for ¡°Nitrogen Intensify,¡± is a three-chamber bag product that provides ¡ãnutritional treatment for critically ill patients with a high risk of muscle loss even with short-term hospitalization and ¡ãthe 'protein: calorie ratio (1.5g:20kcal)' required by critically ill patients. The name comes from nitrogen, which is a component of amino acids.

In addition, the Ntense EF version does not contain electrolytes and is the only 3-chamber bag product licensed in Korea that is approved for Intradialyti

Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)